Addition of Astatine-211-Labeled Anti-CD45 Antibody to TBI as Conditioning for DLAIdentical Marrow Transplantation: A Novel Strategy to Overcome Graft Rejection in a Canine Pre-Sensitization Model: “Radioimmunotherapy to overcome transfusion-induced sensitization”

. Author manuscript; available in PMC: 2022 Jun 1.

Published in final edited form as: Transplant Cell Ther. 2021 Feb 25;27(6):476.e1–476.e7. doi: 10.1016/j.jtct.2021.02.018

Figure 2. Percentage of donor chimerism in granulocytes, mononuclear cells, and CD3+ cells in dogs treated with 211At-anti-CD45 mAb conditioning with 9.2Gy TBI DLA-identical HCT.